Li Ou, Ph.D., Vice President of Research at Avirmax Inc., will chair two scientific sessions at the upcoming American Society of Gene and Cell Therapy (ASGCT) annual meeting in Baltimore between May 7th and 11th, 2024. ASGCT is the largest international society dedicated to understanding, development, and application of gene and cell therapy.
These two sessions that Dr. Ou chairs will be:
Session Title: A3 – AAV Vectors – Capsid Engineering Session 1
Date and Time: Wednesday, May 8, 2024, 3:45 PM
Session Title: 2nd Annual 5-Minute Thesis Challenge
Date and Time: Friday, May 10, 2024, 8:00 AM
Dr. Li Ou is a current committee member of ASGCT and a well-established investigator in preclinical research in AAV gene therapy and gene editing. Dr. Ou joined Avirmax in July 2023 and has since been leading in expanding the Company’s research programs in capsid engineering and in vivo programs.
Home
Entdecke mehr von LabNews
Melde dich für ein Abonnement an, um die neuesten Beiträge per E-Mail zu erhalten.
